col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


37 Results       Page 1

 [1] 
Elsevier: Trends in Immunology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―31 SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences Xinling Wang, Lu Lu, Shibo Jiang
2 [GO] 2023―Dec―24 Double-take: SARS-CoV-2 has evolved to evade human innate immunity, twice Ellen F. Foxman
3 [GO] 2023―Oct―05 Monoclonal antibodies lock down SARS-CoV-2 spike Hsiang-Chi Huang, Davide Angeletti
4 [GO] 2023―Sep―11 Over but not gone: lingering epigenetic effects of COVID-19 Brandon T. Tran, Ruoqiong Cao, Katherine Y. King
5 [GO] 2023―Sep―09 HLA alleles: important pieces to the COVID-19 puzzle Patricia Castro-Santos, Ángel Carracedo, Roberto Díaz-Peña
6 [GO] 2023―Apr―06 Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis Cosima T. Baldari, Anna Onnis, Emanuele Andreano, Giuseppe Del Giudice, Rino Rappuoli
7 [GO] 2023―Mar―29 High-throughput screening of mutations affecting SARS-CoV-2 spike functions Shuai Xia, Zezhong Liu, Shibo Jiang
8 [GO] 2023―Jan―11 COVID-19 VACCINES AND A PERSPECTIVE ON AFRICA Alberto Mantovani, Maria Rescigno, Guido Forni, Francesca Tognon, Giovanni Putoto, Jerry Ictho, Peter Lochoro
9 [GO] 2022―Dec―22 Spiking SARS-CoV-2 anti-viral immunity in the respiratory tract Aaron Silva-Sanchez, Troy D. Randall
10 [GO] 2022―May―07 Insights into how SARS-CoV2 infection induces cytokine storms Kevin John Selva, Amy W. Chung
11 [GO] 2022―Feb―28 SARS-CoV-2 Vaccination Washes Away Original Antigenic Sin Shiv Pillai
12 [GO] 2022―Feb―11 NAD+ in COVID-19 and Viral Infections Minyan Zheng, Michael B. Schultz, David A. Sinclair
13 [GO] 2022―Jan―14 Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concern Shan Su, Weihua Li, Shibo Jiang
14 [GO] 2021―Dec―07 Natural resistance against infections: focus on COVID-19 Mihai G. Netea, Jorge Domínguez-Andrés, Frank L. van de Veerdonk, Reinout van Crevel, Bali Pulendran, Jos W.M. van der Meer
15 [GO] 2021―Nov―19 Apart, together: coping with the COVID-19 pandemic Catarina Sacristán
16 [GO] 2021―Oct―19 Clash of the titans: interferons and SARS-CoV-2 Nolwenn Jouvenet, Caroline Goujon, Arinjay Banerjee
17 [GO] 2021―Sep―15 Immune imprinting and SARS-CoV-2 vaccine design Adam K. Wheatley, Annette Fox, Hyon-Xhi Tan, Jennifer A. Juno, Miles P. Davenport, Kanta Subbarao, Stephen J. Kent
18 [GO] 2021―Jul―12 Why are there so few (or so many) circulating coronaviruses? Benjamin L. Rice, Daniel C. Douek, Adrian B. McDermott, Bryan T. Grenfell, C. Jessica E. Metcalf
19 [GO] 2021―Feb―15 The dual nature of type-I interferons in SARS-CoV-2 induced inflammation Cecile King, Jonathan Sprent
20 [GO] 2020―Dec―24 The Immunologists’ Guide to Pandemic Preparedness Daniela Marín-Hernández, Nathaniel Hupert, Douglas F. Nixon
21 [GO] 2020―Dec―13 Complement factors in COVID-19 therapeutics and vaccines Liriye Kurtovic, James G. Beeson
22 [GO] 2020―Nov―13 Combining Antivirals and Immunomodulators to Fight COVID-19 Vincent Feuillet, Bruno Canard, Alain Trautmann
23 [GO] 2020―Nov―13 T Cells: Warriors of SARS-CoV-2 Infection Paola de Candia, Francesco Prattichizzo, Silvia Garavelli, Giuseppe Matarese
24 [GO] 2020―Nov―02 A Potential Role of Interleukin-10 in COVID-19 Pathogenesis Ligong Lu, Hui Zhang, Danielle J. Dauphars, You-Wen He
25 [GO] 2020―Oct―15 Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines SangJoon Lee, Rudragouda Channappanavar, Thirumala-Devi Kanneganti
26 [GO] 2020―Oct―14 Mechanisms of SARS-CoV-2 transmission and pathogenesis Andrew G. Harrison, Tao Lin, Penghua Wang
27 [GO] 2020―Sep―23 The complement C5a-C5aR1 GPCR axis in COVID-19 therapeutics Trent M. Woodruff, Arun K. Shukla
28 [GO] 2020―Sep―17 Structural basis of SARS-CoV-2 and SARS-CoV-antibody interactions Edem Gavor, Yeu Khai Choong, Shi Yin Er, Hariharan Sivaraman, J. Sivaraman
29 [GO] 2020―Aug―12 Is immunological memory a burden in times of COVID-19? Enrique Ortega
30 [GO] 2020―Aug―11 Effect of low-pathogenic human coronavirus-specific antibodies on SARS-CoV-2 Shibo Jiang, Lanying Du
31 [GO] 2020―Aug―10 Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis Alain Calender, Dominique Israel-Biet, Dominique Valeyre, Yves Pacheco
32 [GO] 2020―Aug―08 Does Cross-Neutralization of SARS-CoV-2 Only Relate to High Pathogenic Coronaviruses? Zhongren Ma, Pengfei Li, Aqsa Ikram, Qiuwei Pan
33 [GO] 2020―Jun―29 Using Serology with Models to clarify the trajectory of the SARS-CoV-2 emerging outbreak C. Jessica E. Metcalf, Cecile Viboud, David Spiro, Bryan T. Grenfell
34 [GO] 2020―Apr―24 Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses Shibo Jiang, Christopher Hillyer, Lanying Du
35 [GO] 2020―Apr―11 Persistence of memory in times of COVID-19 Ger Rijkers
36 [GO] 2020―Apr―02 Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses Shibo Jiang, Christopher Hillyer, Lanying Du
37 [GO] 2020―Mar―12 SARS Coronavirus Redux Enya Qing, Tom Gallagher
 [1] 

37 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.013 sec